China Resources Sanjiu Medical & Pharmaceutical Co Ltd Tangible Net Worth Ratio
China Resources Sanjiu Medical & Pharmaceutical Co Ltd tangible net worth ratio. China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) has a Tangible Net Worth Ratio of 79.1% as of June 2026. This metric is calculated by deducting intangible assets (CN¥8.16 Billion) from net assets (CN¥39.13 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore China Resources Sanjiu Medical & Pharmac net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of China Resources Sanjiu Medical & Pharmaceutical Co Ltd (1997–2025)
Tangible net worth ratio of China Resources Sanjiu Medical & Pharmaceutical Co Ltd from 1997 to 2025. This chart shows how China Resources Sanjiu Medical & Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 29 annual periods from 1997 to 2025. As of June 2026, the ratio stands at 79.1%, reflecting net assets of CN¥39.13 Billion with intangible assets of CN¥8.16 Billion CNY. Check China Resources Sanjiu Medical & Pharmac strategic capital allocation to assess the company's strategic physical and investment asset allocation.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Tangible Net Worth Ratio by Year (1997–2025)
China Resources Sanjiu Medical & Pharmaceutical Co Ltd tangible net worth ratio by year from 1997 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for China Resources Sanjiu Medical & Pharmaceutical Co Ltd from 1997 to 2025, covering 29 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market cap of China Resources Sanjiu Medical & Pharmac.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 79.1% | CN¥38.77 Billion | CN¥8.12 Billion | CN¥58.80 Billion | ▼ -4.7 pp |
| 2024 | 83.8% | CN¥25.26 Billion | CN¥4.09 Billion | CN¥40.08 Billion | ▲ +0.6 pp |
| 2023 | 83.2% | CN¥24.26 Billion | CN¥4.08 Billion | CN¥40.15 Billion | ▼ -1.1 pp |
| 2022 | 84.3% | CN¥17.53 Billion | CN¥2.75 Billion | CN¥27.12 Billion | ▲ +1.1 pp |
| 2021 | 83.2% | CN¥15.77 Billion | CN¥2.65 Billion | CN¥24.54 Billion | ▲ +1.6 pp |
| 2020 | 81.6% | CN¥14.05 Billion | CN¥2.59 Billion | CN¥22.15 Billion | ▼ -2.4 pp |
| 2019 | 83.9% | CN¥13.08 Billion | CN¥2.10 Billion | CN¥21.40 Billion | ▲ +2.2 pp |
| 2018 | 81.7% | CN¥11.17 Billion | CN¥2.04 Billion | CN¥18.03 Billion | ▲ +1.1 pp |
| 2017 | 80.6% | CN¥10.13 Billion | CN¥1.97 Billion | CN¥16.20 Billion | ▲ +1.7 pp |
| 2016 | 78.9% | CN¥8.72 Billion | CN¥1.84 Billion | CN¥13.55 Billion | ▲ +1.9 pp |
| 2015 | 77.0% | CN¥7.67 Billion | CN¥1.76 Billion | CN¥12.02 Billion | ▲ +0.0 pp |
| 2014 | 77.0% | CN¥7.00 Billion | CN¥1.61 Billion | CN¥10.67 Billion | ▲ +2.0 pp |
| 2013 | 74.9% | CN¥6.20 Billion | CN¥1.55 Billion | CN¥9.98 Billion | ▲ +1.1 pp |
| 2012 | 73.8% | CN¥5.61 Billion | CN¥1.47 Billion | CN¥8.67 Billion | ▲ +1.0 pp |
| 2011 | 72.8% | CN¥4.85 Billion | CN¥1.32 Billion | CN¥7.60 Billion | ▼ -0.7 pp |
| 2010 | 73.5% | CN¥4.73 Billion | CN¥1.25 Billion | CN¥6.59 Billion | ▲ +2.6 pp |
| 2009 | 70.9% | CN¥3.95 Billion | CN¥1.15 Billion | CN¥5.63 Billion | ▲ +3.5 pp |
| 2008 | 67.5% | CN¥3.41 Billion | CN¥1.11 Billion | CN¥5.11 Billion | ▼ -29.6 pp |
| 2007 | 97.0% | CN¥2.96 Billion | CN¥87.74 Million | CN¥7.94 Billion | ▼ -0.9 pp |
| 2006 | 97.9% | CN¥2.61 Billion | CN¥55.02 Million | CN¥7.13 Billion | ▼ -0.1 pp |
| 2005 | 98.0% | CN¥2.39 Billion | CN¥47.77 Million | CN¥7.04 Billion | ▲ +0.3 pp |
| 2004 | 97.7% | CN¥2.29 Billion | CN¥51.95 Million | CN¥7.18 Billion | ▲ +0.4 pp |
| 2003 | 97.3% | CN¥3.05 Billion | CN¥81.33 Million | CN¥8.30 Billion | ▲ +0.1 pp |
| 2002 | 97.2% | CN¥2.97 Billion | CN¥83.28 Million | CN¥6.85 Billion | ▼ -0.3 pp |
| 2001 | 97.5% | CN¥2.95 Billion | CN¥74.40 Million | CN¥6.60 Billion | ▲ +0.2 pp |
| 2000 | 97.3% | CN¥2.87 Billion | CN¥78.62 Million | CN¥5.68 Billion | ▼ -1.4 pp |
| 1999 | 98.7% | CN¥2.65 Billion | CN¥35.14 Million | CN¥3.58 Billion | ▲ +2.0 pp |
| 1998 | 96.7% | CN¥747.10 Million | CN¥24.83 Million | CN¥1.71 Billion | ▼ -0.5 pp |
| 1997 | 97.2% | CN¥570.67 Million | CN¥16.25 Million | CN¥1.47 Billion | — |